ANNEXIN PHARM. AB (PUBL)
ANNEXIN PHARM. AB (PUBL)
Share · SE0009664154 · A2DX74 (XSTO)
Overview
No Price
Closing Price XSTO 27.10.2025: 27,00 SEK
27.10.2025 16:19
Current Prices from ANNEXIN PHARM. AB (PUBL)
ExchangeTickerCurrencyLast TradePriceDaily Change
XSTO: NASDAQ STOCKHOLM AB
NASDAQ STOCKHOLM AB
ANNX.ST
SEK
27.10.2025 16:19
27,00 SEK
-0,80 SEK
-2,88 %
Share Float & Liquidity
Free Float 52,14 %
Shares Float 3,68 M
Shares Outstanding 7,06 M
Company Profile for ANNEXIN PHARM. AB (PUBL) Share
Annexin Pharmaceuticals AB (publ), a biotechnology company, develops drug candidates for the treatment of various cardiovascular diseases. The company develops ANXV, a human recombinant protein. It offers Annexin A5 to protect and repair blood vessels and counteract inflammation. The company was founded in 2014 and is based in Stockholm, Sweden.
Get up to date insights from finAgent about ANNEXIN PHARM. AB (PUBL)

Company Data

Name ANNEXIN PHARM. AB (PUBL)
Company Annexin Pharmaceuticals AB (publ)
Website https://www.annexinpharma.com/sv
Primary Exchange XSTO Frankfurt
WKN A2DX74
ISIN SE0009664154
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Anders Haegerstrand
Market Capitalization 199 Mio
Country Sweden
Currency EUR
Employees 0,0 T
Address Drottninggatan 65, 111 36 Stockholm
IPO Date 2017-04-19

Ticker Symbols

Name Symbol
NASDAQ STOCKHOLM AB ANNX.ST
Frankfurt Q91.F
More Shares
Investors who hold ANNEXIN PHARM. AB (PUBL) also have the following shares in their portfolio:
EIB EUR. INV.BK 15/22 MTN
EIB EUR. INV.BK 15/22 MTN Bond
Wells Fargo C&B Large Cap Value Fund - Class Admin
Wells Fargo C&B Large Cap Value Fund - Class Admin Fund
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025